- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.
According to our latest study, the global Nausea And Vomiting Treatment market size was valued at USD 5345.9 million in 2022 and is forecast to a readjusted size of USD 8156.1 million by 2029 with a CAGR of 6.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.
This report is a detailed and comprehensive analysis for global Nausea And Vomiting Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Nausea And Vomiting Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Nausea And Vomiting Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Nausea And Vomiting Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Nausea And Vomiting Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nausea And Vomiting Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nausea And Vomiting Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Nausea And Vomiting Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Others
Market segment by Application
CINV
PONV
Motion Sickness
Pregnancy
Others
Market segment by players, this report covers
Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Pharmanovia
Mylan
Duchesnay
GSK
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nausea And Vomiting Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nausea And Vomiting Treatment, with revenue, gross margin and global market share of Nausea And Vomiting Treatment from 2018 to 2023.
Chapter 3, the Nausea And Vomiting Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nausea And Vomiting Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Nausea And Vomiting Treatment.
Chapter 13, to describe Nausea And Vomiting Treatment research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Nausea And Vomiting Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nausea And Vomiting Treatment by Type
1.3.1 Overview: Global Nausea And Vomiting Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Nausea And Vomiting Treatment Consumption Value Market Share by Type in 2022
1.3.3 Serotonin Receptor Antagonist
1.3.4 Neurokinin NK1 Receptor Antagonist
1.3.5 Others
1.4 Global Nausea And Vomiting Treatment Market by Application
1.4.1 Overview: Global Nausea And Vomiting Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 CINV
1.4.3 PONV
1.4.4 Motion Sickness
1.4.5 Pregnancy
1.4.6 Others
1.5 Global Nausea And Vomiting Treatment Market Size & Forecast
1.6 Global Nausea And Vomiting Treatment Market Size and Forecast by Region
1.6.1 Global Nausea And Vomiting Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Nausea And Vomiting Treatment Market Size by Region, (2018-2029)
1.6.3 North America Nausea And Vomiting Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Nausea And Vomiting Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Nausea And Vomiting Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Nausea And Vomiting Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Nausea And Vomiting Treatment Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Merck & Co. Inc.
2.1.1 Merck & Co. Inc. Details
2.1.2 Merck & Co. Inc. Major Business
2.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Product and Solutions
2.1.4 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck & Co. Inc. Recent Developments and Future Plans
2.2 Helsinn Group
2.2.1 Helsinn Group Details
2.2.2 Helsinn Group Major Business
2.2.3 Helsinn Group Nausea And Vomiting Treatment Product and Solutions
2.2.4 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Helsinn Group Recent Developments and Future Plans
2.3 Unimed Pharmaceuticals (AbbVie Inc.)
2.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Details
2.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Major Business
2.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product and Solutions
2.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments and Future Plans
2.4 Kyowa Kirin
2.4.1 Kyowa Kirin Details
2.4.2 Kyowa Kirin Major Business
2.4.3 Kyowa Kirin Nausea And Vomiting Treatment Product and Solutions
2.4.4 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Kyowa Kirin Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Nausea And Vomiting Treatment Product and Solutions
2.5.4 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Qilu Pharma
2.6.1 Qilu Pharma Details
2.6.2 Qilu Pharma Major Business
2.6.3 Qilu Pharma Nausea And Vomiting Treatment Product and Solutions
2.6.4 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Qilu Pharma Recent Developments and Future Plans
2.7 Teva Pharmaceutical Industries Ltd.
2.7.1 Teva Pharmaceutical Industries Ltd. Details
2.7.2 Teva Pharmaceutical Industries Ltd. Major Business
2.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product and Solutions
2.7.4 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.8 Taiji group
2.8.1 Taiji group Details
2.8.2 Taiji group Major Business
2.8.3 Taiji group Nausea And Vomiting Treatment Product and Solutions
2.8.4 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Taiji group Recent Developments and Future Plans
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Nausea And Vomiting Treatment Product and Solutions
2.9.4 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Novartis Recent Developments and Future Plans
2.10 Heron Therapeutics
2.10.1 Heron Therapeutics Details
2.10.2 Heron Therapeutics Major Business
2.10.3 Heron Therapeutics Nausea And Vomiting Treatment Product and Solutions
2.10.4 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Heron Therapeutics Recent Developments and Future Plans
2.11 Pharmanovia
2.11.1 Pharmanovia Details
2.11.2 Pharmanovia Major Business
2.11.3 Pharmanovia Nausea And Vomiting Treatment Product and Solutions
2.11.4 Pharmanovia Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pharmanovia Recent Developments and Future Plans
2.12 Mylan
2.12.1 Mylan Details
2.12.2 Mylan Major Business
2.12.3 Mylan Nausea And Vomiting Treatment Product and Solutions
2.12.4 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Mylan Recent Developments and Future Plans
2.13 Duchesnay
2.13.1 Duchesnay Details
2.13.2 Duchesnay Major Business
2.13.3 Duchesnay Nausea And Vomiting Treatment Product and Solutions
2.13.4 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Duchesnay Recent Developments and Future Plans
2.14 GSK
2.14.1 GSK Details
2.14.2 GSK Major Business
2.14.3 GSK Nausea And Vomiting Treatment Product and Solutions
2.14.4 GSK Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 GSK Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nausea And Vomiting Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Nausea And Vomiting Treatment by Company Revenue
3.2.2 Top 3 Nausea And Vomiting Treatment Players Market Share in 2022
3.2.3 Top 6 Nausea And Vomiting Treatment Players Market Share in 2022
3.3 Nausea And Vomiting Treatment Market: Overall Company Footprint Analysis
3.3.1 Nausea And Vomiting Treatment Market: Region Footprint
3.3.2 Nausea And Vomiting Treatment Market: Company Product Type Footprint
3.3.3 Nausea And Vomiting Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Nausea And Vomiting Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Nausea And Vomiting Treatment Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Nausea And Vomiting Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global Nausea And Vomiting Treatment Market Forecast by Application (2024-2029)
6 North America
6.1 North America Nausea And Vomiting Treatment Consumption Value by Type (2018-2029)
6.2 North America Nausea And Vomiting Treatment Consumption Value by Application (2018-2029)
6.3 North America Nausea And Vomiting Treatment Market Size by Country
6.3.1 North America Nausea And Vomiting Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Nausea And Vomiting Treatment Consumption Value by Type (2018-2029)
7.2 Europe Nausea And Vomiting Treatment Consumption Value by Application (2018-2029)
7.3 Europe Nausea And Vomiting Treatment Market Size by Country
7.3.1 Europe Nausea And Vomiting Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
7.3.3 France Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region
8.3.1 Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Region (2018-2029)
8.3.2 China Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
8.3.5 India Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
9 South America
9.1 South America Nausea And Vomiting Treatment Consumption Value by Type (2018-2029)
9.2 South America Nausea And Vomiting Treatment Consumption Value by Application (2018-2029)
9.3 South America Nausea And Vomiting Treatment Market Size by Country
9.3.1 South America Nausea And Vomiting Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country
10.3.1 Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Nausea And Vomiting Treatment Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Nausea And Vomiting Treatment Market Drivers
11.2 Nausea And Vomiting Treatment Market Restraints
11.3 Nausea And Vomiting Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Nausea And Vomiting Treatment Industry Chain
12.2 Nausea And Vomiting Treatment Upstream Analysis
12.3 Nausea And Vomiting Treatment Midstream Analysis
12.4 Nausea And Vomiting Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Nausea And Vomiting Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Nausea And Vomiting Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Nausea And Vomiting Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Nausea And Vomiting Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Merck & Co. Inc. Company Information, Head Office, and Major Competitors
Table 6. Merck & Co. Inc. Major Business
Table 7. Merck & Co. Inc. Nausea And Vomiting Treatment Product and Solutions
Table 8. Merck & Co. Inc. Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Merck & Co. Inc. Recent Developments and Future Plans
Table 10. Helsinn Group Company Information, Head Office, and Major Competitors
Table 11. Helsinn Group Major Business
Table 12. Helsinn Group Nausea And Vomiting Treatment Product and Solutions
Table 13. Helsinn Group Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Helsinn Group Recent Developments and Future Plans
Table 15. Unimed Pharmaceuticals (AbbVie Inc.) Company Information, Head Office, and Major Competitors
Table 16. Unimed Pharmaceuticals (AbbVie Inc.) Major Business
Table 17. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product and Solutions
Table 18. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments and Future Plans
Table 20. Kyowa Kirin Company Information, Head Office, and Major Competitors
Table 21. Kyowa Kirin Major Business
Table 22. Kyowa Kirin Nausea And Vomiting Treatment Product and Solutions
Table 23. Kyowa Kirin Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Kyowa Kirin Recent Developments and Future Plans
Table 25. Sanofi Company Information, Head Office, and Major Competitors
Table 26. Sanofi Major Business
Table 27. Sanofi Nausea And Vomiting Treatment Product and Solutions
Table 28. Sanofi Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Sanofi Recent Developments and Future Plans
Table 30. Qilu Pharma Company Information, Head Office, and Major Competitors
Table 31. Qilu Pharma Major Business
Table 32. Qilu Pharma Nausea And Vomiting Treatment Product and Solutions
Table 33. Qilu Pharma Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Qilu Pharma Recent Developments and Future Plans
Table 35. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 36. Teva Pharmaceutical Industries Ltd. Major Business
Table 37. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product and Solutions
Table 38. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 40. Taiji group Company Information, Head Office, and Major Competitors
Table 41. Taiji group Major Business
Table 42. Taiji group Nausea And Vomiting Treatment Product and Solutions
Table 43. Taiji group Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Taiji group Recent Developments and Future Plans
Table 45. Novartis Company Information, Head Office, and Major Competitors
Table 46. Novartis Major Business
Table 47. Novartis Nausea And Vomiting Treatment Product and Solutions
Table 48. Novartis Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Novartis Recent Developments and Future Plans
Table 50. Heron Therapeutics Company Information, Head Office, and Major Competitors
Table 51. Heron Therapeutics Major Business
Table 52. Heron Therapeutics Nausea And Vomiting Treatment Product and Solutions
Table 53. Heron Therapeutics Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Heron Therapeutics Recent Developments and Future Plans
Table 55. Pharmanovia Company Information, Head Office, and Major Competitors
Table 56. Pharmanovia Major Business
Table 57. Pharmanovia Nausea And Vomiting Treatment Product and Solutions
Table 58. Pharmanovia Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Pharmanovia Recent Developments and Future Plans
Table 60. Mylan Company Information, Head Office, and Major Competitors
Table 61. Mylan Major Business
Table 62. Mylan Nausea And Vomiting Treatment Product and Solutions
Table 63. Mylan Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Mylan Recent Developments and Future Plans
Table 65. Duchesnay Company Information, Head Office, and Major Competitors
Table 66. Duchesnay Major Business
Table 67. Duchesnay Nausea And Vomiting Treatment Product and Solutions
Table 68. Duchesnay Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Duchesnay Recent Developments and Future Plans
Table 70. GSK Company Information, Head Office, and Major Competitors
Table 71. GSK Major Business
Table 72. GSK Nausea And Vomiting Treatment Product and Solutions
Table 73. GSK Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. GSK Recent Developments and Future Plans
Table 75. Global Nausea And Vomiting Treatment Revenue (USD Million) by Players (2018-2023)
Table 76. Global Nausea And Vomiting Treatment Revenue Share by Players (2018-2023)
Table 77. Breakdown of Nausea And Vomiting Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Nausea And Vomiting Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 79. Head Office of Key Nausea And Vomiting Treatment Players
Table 80. Nausea And Vomiting Treatment Market: Company Product Type Footprint
Table 81. Nausea And Vomiting Treatment Market: Company Product Application Footprint
Table 82. Nausea And Vomiting Treatment New Market Entrants and Barriers to Market Entry
Table 83. Nausea And Vomiting Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Nausea And Vomiting Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 85. Global Nausea And Vomiting Treatment Consumption Value Share by Type (2018-2023)
Table 86. Global Nausea And Vomiting Treatment Consumption Value Forecast by Type (2024-2029)
Table 87. Global Nausea And Vomiting Treatment Consumption Value by Application (2018-2023)
Table 88. Global Nausea And Vomiting Treatment Consumption Value Forecast by Application (2024-2029)
Table 89. North America Nausea And Vomiting Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 90. North America Nausea And Vomiting Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 91. North America Nausea And Vomiting Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 92. North America Nausea And Vomiting Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 93. North America Nausea And Vomiting Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 94. North America Nausea And Vomiting Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 95. Europe Nausea And Vomiting Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Europe Nausea And Vomiting Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Europe Nausea And Vomiting Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 98. Europe Nausea And Vomiting Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 99. Europe Nausea And Vomiting Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Nausea And Vomiting Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 102. Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 103. Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 104. Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 105. Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 106. Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 107. South America Nausea And Vomiting Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 108. South America Nausea And Vomiting Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 109. South America Nausea And Vomiting Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 110. South America Nausea And Vomiting Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 111. South America Nausea And Vomiting Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 112. South America Nausea And Vomiting Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 114. Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 115. Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 116. Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 117. Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 118. Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 119. Nausea And Vomiting Treatment Raw Material
Table 120. Key Suppliers of Nausea And Vomiting Treatment Raw Materials
List of Figures
Figure 1. Nausea And Vomiting Treatment Picture
Figure 2. Global Nausea And Vomiting Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Nausea And Vomiting Treatment Consumption Value Market Share by Type in 2022
Figure 4. Serotonin Receptor Antagonist
Figure 5. Neurokinin NK1 Receptor Antagonist
Figure 6. Others
Figure 7. Global Nausea And Vomiting Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Nausea And Vomiting Treatment Consumption Value Market Share by Application in 2022
Figure 9. CINV Picture
Figure 10. PONV Picture
Figure 11. Motion Sickness Picture
Figure 12. Pregnancy Picture
Figure 13. Others Picture
Figure 14. Global Nausea And Vomiting Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Nausea And Vomiting Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Nausea And Vomiting Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Nausea And Vomiting Treatment Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Nausea And Vomiting Treatment Consumption Value Market Share by Region in 2022
Figure 19. North America Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Nausea And Vomiting Treatment Revenue Share by Players in 2022
Figure 25. Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Nausea And Vomiting Treatment Market Share in 2022
Figure 27. Global Top 6 Players Nausea And Vomiting Treatment Market Share in 2022
Figure 28. Global Nausea And Vomiting Treatment Consumption Value Share by Type (2018-2023)
Figure 29. Global Nausea And Vomiting Treatment Market Share Forecast by Type (2024-2029)
Figure 30. Global Nausea And Vomiting Treatment Consumption Value Share by Application (2018-2023)
Figure 31. Global Nausea And Vomiting Treatment Market Share Forecast by Application (2024-2029)
Figure 32. North America Nausea And Vomiting Treatment Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Nausea And Vomiting Treatment Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Nausea And Vomiting Treatment Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Nausea And Vomiting Treatment Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Nausea And Vomiting Treatment Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Nausea And Vomiting Treatment Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 42. France Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Nausea And Vomiting Treatment Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Nausea And Vomiting Treatment Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Nausea And Vomiting Treatment Consumption Value Market Share by Region (2018-2029)
Figure 49. China Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. India Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Nausea And Vomiting Treatment Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Nausea And Vomiting Treatment Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Nausea And Vomiting Treatment Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Nausea And Vomiting Treatment Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Nausea And Vomiting Treatment Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Nausea And Vomiting Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Nausea And Vomiting Treatment Consumption Value (2018-2029) & (USD Million)
Figure 66. Nausea And Vomiting Treatment Market Drivers
Figure 67. Nausea And Vomiting Treatment Market Restraints
Figure 68. Nausea And Vomiting Treatment Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Nausea And Vomiting Treatment in 2022
Figure 71. Manufacturing Process Analysis of Nausea And Vomiting Treatment
Figure 72. Nausea And Vomiting Treatment Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
